SLC22A4 and rheumatoid arthritis: It has been shown that OCTN1 is expressed in synovial fibroblasts isolated from tissues of patients with rheumatoid arthritis and that the uptake of saracatinib in these cells was reduced by 80% upon OCTN1 silencing [41].